[Infections in patients with acute myeloid leukemia]

Area of Science:

• Hematology
• Infectious Diseases
• Oncology

Context:

• Acute myeloid leukemia (AML) patients undergoing therapy experience frequent infections.
• Cytotoxic agents damage the mucosal barrier, increasing susceptibility to endogenous pathogens.
• Prolonged neutropenia is a significant risk factor for both bacterial and fungal infections.

Purpose:

• To highlight the critical nature of infections in AML patients.
• To emphasize the diagnostic challenges posed by neutropenia.
• To stress the urgency of initiating anti-infective therapy.

Summary:

• Infections are a major complication in AML therapy, often presenting with fever as the sole indicator due to neutropenia.
• Gram-positive bacterial infections are most common, but gram-negative infections carry a higher risk of sepsis and mortality.
• Invasive fungal infections are also a concern, while viral causes of neutropenic fever are rare.

Impact:

• Recognizing fever as a hematologic emergency in neutropenic patients is vital.
• Timely diagnosis and appropriate anti-infective treatment are essential for patient survival.
• Understanding infection risks aids in developing preventative and therapeutic strategies for AML patients.